Taro Pharmaceutical Industries Ltd expected to post earnings of 31  cents a share - Earnings Preview

Taro Pharmaceutical Industries

25/07/2023 03:02

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a fall in quarterly revenue when it reports  results on
July 26. 
    * The Haifa Israel-based   company is expected to report  a
4.9% decrease in revenue to $149.027 million from $156.67
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of 31 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $35​, below​ its last closing
price of $37.57. ​​​

This summary was machine generated July 25 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated